Literature DB >> 29553334

Intensive Care Admissions for Severe Chikungunya Virus Infection, French Polynesia.

Adrien Koeltz, Stephane Lastere, Sylvain Jean-Baptiste.   

Abstract

During the 2014-2015 chikungunya outbreak in French Polynesia, 64 patients with confirmed chikungunya virus infection were admitted into intensive care. Sixty-three were nonpregnant adults; 11 had an atypical form, 21 had severe sepsis or septic shock, and 18 died. These findings indicate that critical illness frequently complicates the course of chikungunya virus infection.

Entities:  

Keywords:  CHIKV; Chikungunya; French Polynesia; Guillain-Barré syndrome; arboviruses; encephalopathy; intensive care; myocarditis; sepsis; vector-borne infections; viruses

Mesh:

Year:  2018        PMID: 29553334      PMCID: PMC5875279          DOI: 10.3201/eid2404.161536

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


The first case of chikungunya virus (CHIKV) infection in French Polynesia (Tahiti) was diagnosed in May 2014; it was imported from Guadeloupe Island in the Caribbean (). During the outbreak that developed during October 2014–March 2015, ≈25% of the local population (272,000 residents) became infected with CHIKV (). French Polynesia has 2 potential mosquito vectors for CHIKV: Aedes aegypti and A. polynesiensis. Phylogenic analysis showed that the French Polynesia strain of CHIKV belongs to the Asian lineage and is closely related to the strain collected in Guadeloupe and the British Virgin Islands in 2014, showing 99.9% homology with that strain (). To describe patient characteristics and clinical courses of chikungunya patients in French Polynesia during 2014–2015, we retrospectively reviewed the medical files of all patients with documented CHIKV infection. CHIKV infection was defined by the association of compatible symptoms of fever and arthralgia and positive IgM serology or positive blood reverse transcription PCR (RT-PCR). We defined types of CHIKV infection as follows: 1) common form (i.e., only fever or arthralgia); 2) atypical form (i.e., involvement of >1 organ systems); and 3) severe form (i.e., failure of >1 organ systems or admission to an intensive care unit [ICU]). We used standard definitions for organ system failures and severe sepsis shock (). Organ failures were defined by a Sequential Organ Failure Assessment score >3 for each organ. Encephalitis was defined in accordance with Consensus Statement of the International Encephalitis Consortium criteria () and myocarditis in accordance with Position Statement of the European Society of Cardiology criteria (). During the outbreak, CHIKV was confirmed in 63 adults and one 11-year-old girl (Table). Forty-two patients had positive results for blood RT-PCR, and 22 had positive results for IgM serology. Virus load in serum was high; median load was 7.52 log10 copies/mL (interquartile range 3.47–9.39 log10 copies/mL). Of 5 patients with encephalitis symptoms, 3 had positive results for cerebrospinal fluid RT-PCR.
Table

Clinical and laboratory characteristics of 64 patients with chikungunya virus infection admitted into the intensive care department, French Polynesia, 2014–2015*

CharacteristicResult
Baseline
Median age, y (IQR)62 (49–71)
Sex, no. (%)
M37 (58)
F27 (42)
Preexisting disease, no. (%)
Hypertension37 (58)
Diabetes mellitus22 (34)
Chronic renal failure15 (23)
Chronic heart failure12 (19)
Chronic liver disease3 (5)
None
15 (23)
Simplified Acute Physiology Score (IQR)
48 (28.5–68.5)
Chikungunya diagnosis, no. (%)
By reverse transcription PCR42 (66)
By IgM26 (41)
By reverse transcription PCR and IgM
4 (6)
Finding at admission
Organ failure,† no. (%)
Hemodynamic40 (63)
Renal30 (47)
Neurologic20 (31)
Respiratory33 (52)
Hepatic16 (25)
Hematologic9 (14)
Laboratory‡
Leukocyte count, cells/m3, median (IQR)11,600 (7,200–15,200)
Lymphocyte count, cells/m3, median (IQR)1,000 (600–1,500)
Lymphopenia, <1,000 cells/m3 (% of patients)36 (56)
Platelet count, cells/m3, median (IQR)155,000 (79–208)
Platelet count, <150,000 cells/m3 (% of patients)34,000 (53)
Creatinine, μmol/L, median (IQR)132 (79–184)
Creatine phosphokinase, mmol/L, median (IQR)222 (124–1,160)
Alanine aminotransferase, UI/L, median (IQR)35 (19–76)
C-reactive protein, mg/L, median (IQR)10.6 (2.8–18.3)
Procalcitonin, μg/L, median (IQR)1.72 (0.42–18.3)
Lactate, mmol/L, median (IQR)
2.6 (1.1–5.4)
Chikungunya reverse transcription PCR‡
Viral load in serum, log10 copies/mL (IQR)7.52 (3.47–9.39)
Viral load in cerebrospinal fluid,§ log10 copies/mL (IQR)
4.18 (3.86–4.26)
Outcome variable
ICU length of stay, d, median (IQR)3 (2–7)
Crude intensive care unit deaths, no (%)18 (28)

*IQR, interquartile range.
†Organ failure is defined according to a Sequential Organ Failure Assessment score >3 for each organ.
‡Blood samples during the first 24 h. Reference values are as follows: leukocytes, 4.0–10.0 × 103 cells/mm3; lymphocytes, 1.5–3.4 × 103 cells/mm3; platelets, 150–400 × 103/mm3; creatinine, 0.56–1.0 mg/dL; creatine phosphokinase, 0–130 U/L; alanine aminotransferase, 0–35 U/L; C-reactive protein, <5 mg/L; procalcitonin, <0.5 ng/mL; lactate, 5–15 mg/dL.
§Virus load was positive for 5 of the 9 cerebrospinal fluid samples.

*IQR, interquartile range.
†Organ failure is defined according to a Sequential Organ Failure Assessment score >3 for each organ.
‡Blood samples during the first 24 h. Reference values are as follows: leukocytes, 4.0–10.0 × 103 cells/mm3; lymphocytes, 1.5–3.4 × 103 cells/mm3; platelets, 150–400 × 103/mm3; creatinine, 0.56–1.0 mg/dL; creatine phosphokinase, 0–130 U/L; alanine aminotransferase, 0–35 U/L; C-reactive protein, <5 mg/L; procalcitonin, <0.5 ng/mL; lactate, 5–15 mg/dL.
§Virus load was positive for 5 of the 9 cerebrospinal fluid samples. Forty-nine (76%) patients had a preexisting disease, 33 (51%) required invasive mechanical ventilation, 40 (62%) were in shock and needed vasoactive drugs, and 30 (46%) required renal replacement therapy. The ICU death rate for chikungunya was 28%, slightly higher than the usual 22% ICU death rate (A. Koeltz, unpub. data). Five patients had encephalitis, 2 had myocarditis, and 4 had Guillain-Barré syndrome (GBS). Fifty-five patients had a severe form of chikungunya, and 21 had illness consistent with the case definition for severe sepsis; for 2 patients, no other cause for GBS than CHIKV was identified. Two patients had CHIKV–leptospirosis co-infection, and 1 had CHIKV–dengue virus co-infection. Among the 55 patients who had the severe form of chikungunya, 17 had exacerbations of a chronic condition. Chikungunya can be complicated by severe multiple organ failure and lead to death either from exacerbation of a preexisting disease or by severe atypical infection. Severe septic shock directly attributable to CHIKV was reported during the 2014 outbreak (,), and these reports seem consistent with our study (2 cases). This finding could be explained by the fact that chikungunya induces lymphopenia. Neurologic complications of arbovirus infections are well documented, as illustrated by the high incidence of GBS reported during French Polynesia’s outbreak of Zika virus (42 cases) (). In our study, we observed 4 severe cases of GBS, and 10 GBS cases were managed in the hospital during the outbreak; GBS incidence was 4 times higher than usually observed in this hospital. The most severe atypical complication in our study was myocarditis (2 cases), which had a 100% case-fatality rate. These deaths included an 11-year-old child and a 56-year-old woman without preexisting disease. Our findings indicate that critical illness frequently complicates the course of CHIKV infection. Hospitals in chikungunya-endemic areas should be aware of the potential for increases in the number of ICU admissions during outbreaks.
  9 in total

1.  Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.

Authors:  Alida L P Caforio; Sabine Pankuweit; Eloisa Arbustini; Cristina Basso; Juan Gimeno-Blanes; Stephan B Felix; Michael Fu; Tiina Heliö; Stephane Heymans; Roland Jahns; Karin Klingel; Ales Linhart; Bernhard Maisch; William McKenna; Jens Mogensen; Yigal M Pinto; Arsen Ristic; Heinz-Peter Schultheiss; Hubert Seggewiss; Luigi Tavazzi; Gaetano Thiene; Ali Yilmaz; Philippe Charron; Perry M Elliott
Journal:  Eur Heart J       Date:  2013-07-03       Impact factor: 29.983

2.  The burden of chikungunya in the Pacific.

Authors:  T X Nhan; D Musso
Journal:  Clin Microbiol Infect       Date:  2015-03-05       Impact factor: 8.067

3.  Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium.

Authors:  A Venkatesan; A R Tunkel; K C Bloch; A S Lauring; J Sejvar; A Bitnun; J-P Stahl; A Mailles; M Drebot; C E Rupprecht; J Yoder; J R Cope; M R Wilson; R J Whitley; J Sullivan; J Granerod; C Jones; K Eastwood; K N Ward; D N Durrheim; M V Solbrig; L Guo-Dong; C A Glaser
Journal:  Clin Infect Dis       Date:  2013-07-15       Impact factor: 9.079

Review 4.  Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.

Authors:  R Phillip Dellinger; Jean M Carlet; Henry Masur; Herwig Gerlach; Thierry Calandra; Jonathan Cohen; Juan Gea-Banacloche; Didier Keh; John C Marshall; Margaret M Parker; Graham Ramsay; Janice L Zimmerman; Jean-Louis Vincent; Mitchell M Levy
Journal:  Crit Care Med       Date:  2004-03       Impact factor: 7.598

5.  Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study.

Authors:  Van-Mai Cao-Lormeau; Alexandre Blake; Sandrine Mons; Stéphane Lastère; Claudine Roche; Jessica Vanhomwegen; Timothée Dub; Laure Baudouin; Anita Teissier; Philippe Larre; Anne-Laure Vial; Christophe Decam; Valérie Choumet; Susan K Halstead; Hugh J Willison; Lucile Musset; Jean-Claude Manuguerra; Philippe Despres; Emmanuel Fournier; Henri-Pierre Mallet; Didier Musso; Arnaud Fontanet; Jean Neil; Frédéric Ghawché
Journal:  Lancet       Date:  2016-03-02       Impact factor: 79.321

6.  Chikungunya outbreak, French Polynesia, 2014.

Authors:  Maite Aubry; Anita Teissier; Claudine Roche; Vaea Richard; Aurore Shan Yan; Karen Zisou; Eline Rouault; Véronique Maria; Stéphane Lastère; Van-Mai Cao-Lormeau; Didier Musso
Journal:  Emerg Infect Dis       Date:  2015-04       Impact factor: 6.883

7.  Chikungunya virus imported into French Polynesia, 2014.

Authors:  Tu-Xuan Nhan; Aurore Claverie; Claudine Roche; Anita Teissier; Marc Colleuil; Jean-Marie Baudet; Van-Mai Cao-Lormeau; Didier Musso
Journal:  Emerg Infect Dis       Date:  2014-10       Impact factor: 6.883

8.  Severe Sepsis and Septic Shock Associated with Chikungunya Virus Infection, Guadeloupe, 2014.

Authors:  Amélie Rollé; Kinda Schepers; Sylvie Cassadou; Elodie Curlier; Benjamin Madeux; Cécile Hermann-Storck; Isabelle Fabre; Isabelle Lamaury; Benoit Tressières; Guillaume Thiery; Bruno Hoen
Journal:  Emerg Infect Dis       Date:  2016-05       Impact factor: 6.883

9.  Chikungunya fever: Atypical and lethal cases in the Western hemisphere: A Venezuelan experience.

Authors:  Jaime R Torres; Julio S Castro; Libsen Rodríguez; Víctor Saravia; Joanne Arvelaez; Antonio Ríos-Fabra; María A Longhi; Melania Marcano
Journal:  IDCases       Date:  2014-12-18
  9 in total
  5 in total

1.  Immunopathogenesis of alphaviruses.

Authors:  Victoria K Baxter; Mark T Heise
Journal:  Adv Virus Res       Date:  2020-07-08       Impact factor: 9.937

2.  Classification of chikungunya cases: a proposal.

Authors:  Carlos Alexandre Antunes de Brito; André Ricardo Ribas Freitas; Rodrigo Fabiano Said; Melissa Barreto Falcão; Rivaldo Venâncio da Cunha; André Machado Siqueira; Maria Glória Teixeira; Guilherme Sousa Ribeiro; Marina Coelho Moraes de Brito; Luciano Pamplona de Góes Cavalcanti
Journal:  Rev Soc Bras Med Trop       Date:  2020-11-25       Impact factor: 1.581

3.  Risk factors for hospitalization of patients with chikungunya virus infection at sentinel hospitals in Puerto Rico.

Authors:  Christopher H Hsu; Fabiola Cruz-Lopez; Danulka Vargas Torres; Janice Perez-Padilla; Olga D Lorenzi; Aidsa Rivera; J Erin Staples; Esteban Lugo; Jorge Munoz-Jordan; Marc Fischer; Carlos Garcia Gubern; Brenda Rivera Garcia; Luisa Alvarado; Tyler M Sharp
Journal:  PLoS Negl Trop Dis       Date:  2019-01-14

4.  Imported Arbovirus Infections in Spain, 2009-2018.

Authors:  Francesca F Norman; César Henríquez-Camacho; Marta Díaz-Menendez; Sandra Chamorro; Diana Pou; Israel Molina; Josune Goikoetxea; Azucena Rodríguez-Guardado; Eva Calabuig; Clara Crespillo; Inés Oliveira; José-Antonio Pérez-Molina; Rogelio López-Velez
Journal:  Emerg Infect Dis       Date:  2020-04       Impact factor: 6.883

Review 5.  Arboviral Disease Outbreaks in the Pacific Islands Countries and Areas, 2014 to 2020: A Systematic Literature and Document Review.

Authors:  Rosie J Matthews; Ishani Kaluthotage; Tanya L Russell; Tessa B Knox; Paul F Horwood; Adam T Craig
Journal:  Pathogens       Date:  2022-01-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.